Redeye: Imint - Difficult market and revised financial targets ahead
Redeye updates its estimates following Imint’s Q1 2023 report and the press release on May 24, regarding to the loss of future design-ins from a previously important Chinese customer, which will likely cause a substantial decrease in revenue in the coming quarters.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/